Work

Repurposing drugs to treat cardiovascular disease in the era of precision medicine

Year: 2022

Type: review

Source: Nature Reviews Cardiology

DOI: 10.1038/s41569-022-00717-6

Authors: Mena Abdelsayed, Eric J. Kort, Stefan Jovinge, Mark Mercola

Institutions: Stanford Medicine, Stanford Cardiovascular Institute, Stanford University, Van Andel Institute, Spectrum Health, Corewell Health Blodgett Hospital, Lund University, The University of Texas Southwestern Medical Center

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Drug Discovery

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Heart Rhythm Society, Fondation Leducq, National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: Targeting the genotype to phenotype link in HCM as a therapeutic strategy, High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy, G7004739410, Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology

OpenAlex ID: W4281297752

FWCI: 1.691

Cites: 128

Cited by: 95

Related to: 10